Four companies have received FDA warning letters for selling products online that agency officials said made unproven anticancer claims and contained a component of the marijuana plant.
The products reportedly contained cannabidiol (CBD), which isn’t FDA approved for any indication. Such products are marketed in a variety of forms including oil drops, capsules, syrup, tea, and topical lotion or cream. Selling unapproved products with unsubstantiated therapeutic claims violates the federal Food, Drug, and Cosmetic Act and could harm patients, according to FDA officials.
Voelker R. FDA Pursues Unproven Cancer Claims. JAMA. 2017;318(23):2288. doi:10.1001/jama.2017.19150
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: